Part ofpublic health →

FEDERALhearing transcript

High Impact

Senate Hearing on National Public Health Preparedness

Original title: FACING 21ST CENTURY PUBLIC HEALTH THREATS: OUR NATION'S PREPAREDNESS AND RESPONSE CAPABILITIES, PART I

January 1, 2019

public health national security biodefense emergency preparedness legislation

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The committee is reviewing the Pandemic and All-Hazards Preparedness Act to address identified gaps in national security and public health response capabilities, which directly impacts how the federal government funds and coordinates emergency .

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Department of Health and Human Services

The agency's preparedness and response programs are subject to the reauthorization and oversight of the committee.

Food and Drug Administration

The agency's role in approving and managing medical countermeasures is a central focus of the legislative review.

Centers for Disease Control and Prevention

The agency's public health preparedness and response infrastructure is being evaluated for potential legislative updates.

What changed

Last recorded activity January 1, 2019.

What's next

Next step not available in the current record.

Summary

The Senate Committee on Health, Education, Labor, and Pensions held a hearing to evaluate the nation's readiness for 21st-century public health threats, including chemical, biological, and radiological risks. This session served as the first of two hearings aimed at reviewing and reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA).

Key Facts

The hearing was held on January 17, 2018, by the Senate Committee on Health, Education, Labor, and Pensions.
The committee is conducting a review for the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006.
The hearing focused on national preparedness for chemical, biological, radiological, and nuclear threats.
A second hearing on the same topic was scheduled for January 23, 2018.
The 2015 Blue Ribbon Study Panel on Biodefense report identified serious gaps and vulnerabilities in the nation's current public health response capabilities.

Frequently Asked Questions

What is the purpose of this hearing?

The hearing is part of a legislative process to review and reauthorize the Pandemic and All-Hazards Preparedness Act, which governs how the U.S. prepares for major public health threats.

What kind of threats are being discussed?

The committee is discussing preparedness for chemical, biological, radiological, and nuclear threats, as well as general public health emergencies.

Why It Matters

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Biodefense Focus

The committee is explicitly framing the reauthorization of public health law as a national security priority rather than just a health policy issue.

Pandemic and All-Hazards Preparedness Act of 2006

Connected Entities

personScott Gottlieb“Commissioner, U.S. Food and Drug Administration”Map →

personStephen C. Redd“Director, Office of Public Health Preparedness and Response, CDC”Map →

personRichard Burr“Presiding Senator for the hearing”Map →

personLamar Alexander“Chairman of the Committee on Health, Education, Labor, and Pensions”Map →

personRobert Kadlec“Assistant Secretary for Preparedness and Response, HHS”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance75
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools